Fundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study

    Alimentary Pharmacology and Therapeutics, Vol. 58, Núm. 1, pp. 60-70

2022

  1. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

    Gastroenterology, Vol. 163, Núm. 5, pp. 1242-1251.e2

2021

  1. Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview

    Molecular Diagnosis and Therapy, Vol. 25, Núm. 5, pp. 563-576

2015

  1. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastricneuroendocrine tumour

    Human Molecular Genetics, Vol. 24, Núm. 10, pp. 2914-2922